How Brexit affects pharma
Producing powerful, relevant user experiences will be one key area to target
Dr Josep Figueras on survival, access to treatments and the need for good data in oncology
MAPs represent a unique opportunity to gather evidence from a cohort of patients receiving the same treatment, across multiple countries prospectively before launch
Creating a coherent strategy to bridge the divide between digital and other elements of the marketing mix.
Despite a slow uptake of RWE, there is an increasing trend in the use of healthcare system data to inform clinical practice